PT-141 dosage chart explained: FDA-approved 1.75 mg for women, off-label 1–2 mg for men, plus mL conversion and safety notes. Consult a doctor.
There is no single universal PT-141 dosage chart that fits everyone. The only FDA-approved dose is 1.75 mg injected under the skin (subcutaneously) for premenopausal women with hypoactive sexual desire disorder, sold as Vyleesi. Men often use off-label doses of 1 to 2 mg in research settings, but PT-141 is not FDA-approved for men.
What Is PT-141 and Why Dosage Matters
PT-141 (bremelanotide) is a synthetic peptide that activates melanocortin receptors in the brain. It is not a hormone and does not directly increase blood flow like Viagra. Dosage matters because higher amounts do not necessarily improve results and can worsen side effects such as nausea and blood pressure changes. Anyone considering PT-141 should talk with a healthcare professional first.
PT-141 Dosage Chart for Men and Women
The table below summarizes typical doses reported in FDA labeling and clinical research. This is a general reference, not a prescription.
| Group | Typical Dose | Route | Frequency | FDA Status |
|---|---|---|---|---|
| Premenopausal women with HSDD | 1.75 mg | Subcutaneous | Once per 24 hours as needed, max 8 doses per month | FDA-approved (Vyleesi) |
| Men (off-label) | 1–2 mg | Subcutaneous | Once per 24 hours as needed | Not FDA-approved |
| Postmenopausal women (off-label) | 1.75 mg | Subcutaneous | Once per 24 hours as needed | Not FDA-approved |
| Bodybuilding (non-medical) | Not recommended | Injection | N/A | Not FDA-approved |
These doses are not interchangeable. The FDA-approved dose for women is fixed at 1.75 mg. Men using PT-141 off-label often start at 1 mg and adjust based on side effects, but no official guideline exists.
A more detailed pt-141 peptide dosage chart may include body weight, medical history, and other medications. However, no standard dosing chart exists for men because the drug is not approved for male use.
PT-141 Dosage for Women (FDA-Approved)
For premenopausal women with hypoactive sexual desire disorder, the approved dose is 1.75 mg subcutaneous. Inject into the abdomen or thigh. Do not use more than once in 24 hours and no more than 8 times per month.
Vyleesi is given as a prefilled autoinjector pen, so there is no mixing required. The pen delivers exactly 1.75 mg.
Common side effects include nausea, flushing, and headache. Some women experience a temporary rise in blood pressure. A pt-141 dosage for women should always be confirmed by a prescriber, especially if you have heart disease or uncontrolled hypertension.
PT-141 Dosage for Men (Off-Label)
Men use PT-141 off-label for erectile dysfunction or low sexual desire. Clinical studies have tested doses from 0.5 mg to 6 mg, but 1–2 mg is a common starting point in research. Higher doses tend to cause more nausea.
Some studies used 2 mg or higher, but the risk of nausea and blood pressure changes increases with dose. A doctor may recommend starting with 1 mg or less. There is no FDA-approved pt-141 dosage male.
Many men seek a pt-141 peptide dosage for men online, but self-dosing is risky. Start low and work with a doctor who can monitor side effects.
PT-141 Dosage in mL: Converting mg to Units
PT-141 is sold as a lyophilized powder that must be mixed with bacteriostatic water. The concentration depends on how much water you add. A pt-141 dosage in ml always depends on that concentration.
For a 10 mg vial:
- 1 mL water = 10 mg/mL, so 1.75 mg = 0.175 mL (17.5 units on a U-100 insulin syringe)
- 2 mL water = 5 mg/mL, so 1.75 mg = 0.35 mL (35 units)
- 3 mL water = 3.33 mg/mL, so 1.75 mg = 0.525 mL (52.5 units)
| Vial Size | Water Added | Concentration | 1 mg Dose | 1.75 mg Dose |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 0.1 mL | 0.175 mL |
| 10 mg | 2 mL | 5 mg/mL | 0.2 mL | 0.35 mL |
| 10 mg | 3 mL | 3.33 mg/mL | 0.3 mL | 0.525 mL |
If you have a 5 mg vial, the math changes. For example, 1 mL water in a 5 mg vial gives 5 mg/mL, so 1.75 mg = 0.35 mL. Always double-check your math and use a new needle each time. If you are unsure, ask a pharmacist or healthcare professional to verify the dose.
Safety, Side Effects, and Legal Status
PT-141 is FDA-approved only for premenopausal women with HSDD. It is not approved for men, for postmenopausal women, or for pt-141 dosage bodybuilding. Side effects include nausea, vomiting, flushing, headache, injection site reactions, and transient increases in blood pressure.
In the United States, PT-141 for men is often purchased from research chemical websites, which are not regulated for human use. The FDA has warned against using unapproved peptides.
Do not use PT-141 if you have uncontrolled high blood pressure, heart disease, or are pregnant. Avoid combining it with alcohol or other vasodilators. PT-141 is not a cure for sexual dysfunction, and it should only be used under medical supervision.
Frequently Asked Questions
What is the standard PT-141 dosage?
The only FDA-approved dose is 1.75 mg injected subcutaneously for premenopausal women with hypoactive sexual desire disorder. It should be used no more than once every 24 hours and no more than 8 times per month. There is no FDA-approved dose for men.
How many mL is 1.75 mg of PT-141?
The volume depends on the concentration. If you reconstitute a 10 mg vial with 1 mL of water, 1.75 mg equals 0.175 mL. If you use 2 mL of water, it equals 0.35 mL. Always use a U-100 insulin syringe and confirm the concentration with a healthcare professional.
Is PT-141 FDA-approved for men?
No. PT-141 (bremelanotide) is only FDA-approved under the brand name Vyleesi for premenopausal women with hypoactive sexual desire disorder. Men use it off-label in research settings, but it is not approved for male use, and self-dosing carries risks.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.